Country |
|
Year |
No. of clients |
Mean age (years) |
Age <25 (%) |
Age 35+ (%) |
Male (%) |
Injecting main drug (%) |
|---|---|---|---|---|---|---|---|---|
Belgium |
(1) |
1999 |
4826 |
24.5 |
63.0 |
13.0 |
76.0 |
8.0 |
Czech Republic |
|
2003 |
4158 |
21.9 |
74.0 |
4.0 |
67.0 |
57.2 |
Denmark |
|
2003 |
1745 |
28.3 |
44.8 |
23.0 |
75.9 |
8.3 |
Germany |
|
2003 |
10883 |
24.2 |
66.0 |
11.0 |
82.0 |
|
Greece |
|
2003 |
1903 |
27.3 |
49.0 |
18.5 |
83.3 |
40.1 |
Spain |
(2) |
2002 |
17228 |
28.3 |
37.0 |
20.0 |
85.0 |
5.9 |
France |
(3) |
2003 |
7208 |
28.5 |
39.1 |
21.7 |
80.0 |
|
Ireland |
(4) |
2002 |
2012 |
23.3 |
66.1 |
7.5 |
76.4 |
15.7 |
Italy |
|
2003 |
33628 |
29.5 |
32.6 |
25.8 |
87.2 |
|
Cyprus |
|
2003 |
130 |
26.2 |
52.3 |
14.6 |
90.0 |
46.2 |
Latvia |
|
2003 |
143 |
25.3 |
59.6 |
6.0 |
76.0 |
69.1 |
Lithuania |
|
2003 |
356 |
26.6 |
48.0 |
10.4 |
79.2 |
|
Luxembourg |
|
2003 |
24 |
27.3 |
|
|
|
|
Hungary |
|
2003 |
5958 |
27.0 |
51.0 |
16.0 |
67.0 |
|
Malta |
|
2003 |
256 |
23.2 |
63.1 |
6.0 |
82.8 |
|
Netherlands |
|
2003 |
5104 |
29.7 |
38.0 |
27.0 |
78.6 |
2.0 |
Austria |
(5) |
2003 |
891 |
25.9 |
53.7 |
15.2 |
75.0 |
100.0 |
Poland |
(6) |
2002 |
6537 |
|
|
|
|
|
Portugal |
|
2003 |
5085 |
31.2 |
19.4 |
31.2 |
83.5 |
29.5 |
Slovenia |
(7) |
2003 |
504 |
23.2 |
69.9 |
5.0 |
75.8 |
49.8 |
Slovakia |
|
2003 |
877 |
23.5 |
70.1 |
7.2 |
76.0 |
33.6 |
Finland |
|
2003 |
812 |
23.6 |
69.3 |
9.0 |
69.3 |
37.4 |
Sweden |
|
2003 |
1096 |
30.0 |
44.8 |
31.5 |
66.0 |
21.3 |
United Kingdom |
(8) |
2003 |
28087 |
28.7 |
38.8 |
21.3 |
72.0 |
28.0 |
Bulgaria |
|
2003 |
462 |
22.2 |
80.3 |
2.7 |
79.6 |
61.7 |
Romania |
|
2003 |
924 |
26.5 |
62.0 |
14.0 |
75.0 |
|
Notes: Data were not available for: Estonia, Norway, Turkey. (1) Last data available refer to 1999. (2) Last data available refer to 2002. (3) Data on treatment demand referred to the annual census on clients in treatment carried out in November 2003. (4) Last data available refer to 2002. (5) Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%. (6) Last data available refer to 2002. Only data available on first treatment is the total number of cases. (7) Data refer only to outpatient treatment centres. (8) Data relate to the period from 1 April 2002 to 31 March 2003 for Scotland and Northern Ireland; for England from April 2003 to March 2004; Wales: six months periods ending 30 September 2001 and 31 March 2002 combined. Sources: 2004 Reitox national reports - standard table 3 See [Table TDI-1] for details on sources. | ||||||||